Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...

Reviewing the bioequivalence study of the antidiabetic drug Semaglutide of MSN Laboratories, the Subject Expert Committee ...

Ozempic’s active ingredient is semaglutide, which belongs to a class of medications called incretin mimetics, and was approved as a treatment for type 2 diabetes via a 1-milligram injection in 2017.

A new study published in the Obesity Journal found that anti-obesity injections may have a lesser impact on weight loss in a real-world context compared to clinical trials, as patients tend to ...